Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

NCT04453046 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Eligible subjects at study site

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DEVICE: Hemopurifier
DRUG: Pembrolizumab 200mg IV

Sponsor

Aethlon Medical Inc.